CDIO Insider Trading

Insider Ownership Percentage: 13.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Cardio Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Cardio Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardio Diagnostics Share Price & Price History

Current Price: $2.84
Price Change: Price Increase of +0.02 (0.71%)
As of 12/18/2025 04:58 PM ET

This chart shows the closing price history over time for CDIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cardio Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2024Meeshanthini DoganCTOBuy2,298$8.70$19,992.606,577View SEC Filing Icon  
9/6/2024Robert PhilibertInsiderBuy1,135$8.70$9,874.5056,128View SEC Filing Icon  
8/31/2023Meeshanthini DoganCEOBuy549$16.50$9,058.504,278View SEC Filing Icon  
8/28/2023Robert PhilibertInsiderBuy600$18.00$10,800.0054,993View SEC Filing Icon  
8/25/2023Meeshanthini DoganCEOBuy59$16.80$991.203,728View SEC Filing Icon  
8/24/2023Robert PhilibertInsiderBuy533$18.00$9,594.0054,393View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cardio Diagnostics (NASDAQ:CDIO)

8.06% of Cardio Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CDIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cardio Diagnostics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Citadel Advisors LLC19,520$79K0.0%N/A1.069%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC13,365$48K0.0%-96.6%0.769%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC80,834$27K0.0%-28.2%4.656%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC256,941$0.24M0.0%N/A0.635%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC112,564$0.10M0.0%N/A0.278%Search for SEC Filing on Google Icon
2/14/2025Two Sigma Securities LLC52,682$48K0.0%N/A0.130%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC364,387$0.33M0.0%+97.6%0.901%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.12,000$30K0.0%N/A0.058%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC110,000$0.13M0.0%N/A1.134%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP23,646$26K0.0%N/A0.249%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cardio Diagnostics logo
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Read More on Cardio Diagnostics

Today's Range

Now: $2.84
Low: $2.81
High: $3.01

50 Day Range

MA: $3.61
Low: $2.48
High: $4.55

52 Week Range

Now: $2.84
Low: $2.42
High: $39.30

Volume

12,090 shs

Average Volume

51,890 shs

Market Capitalization

$5.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.92

Who are the company insiders with the largest holdings of Cardio Diagnostics?

Cardio Diagnostics' top insider shareholders include:
  1. Robert Philibert (Insider)
  2. Meeshanthini Dogan (CTO)
Learn More about top insider investors at Cardio Diagnostics.

Who are the major institutional investors of Cardio Diagnostics?

Cardio Diagnostics' top institutional shareholders include:
  1. Citadel Advisors LLC — 1.07%
Learn More about top institutional investors of Cardio Diagnostics stock.

Which major investors are buying Cardio Diagnostics stock?

During the last quarter, CDIO stock was purchased by institutional investors including:
  1. Citadel Advisors LLC
During the previous year, these company insiders have bought Cardio Diagnostics stock:
  1. Robert Philibert (Insider)
  2. Meeshanthini Dogan (CTO)
Learn More investors buying Cardio Diagnostics stock.